Study Alleges Mortality Miscount in FOURIER Trial; TIMI Group Disagrees

Clinical trialists, including Marc Sabatine, as well as evolocumab’s manufacturer reject the reanalysis as flawed and sensationalistic.

Related Keywords

Spain ,Canada ,Boston ,Massachusetts ,United States ,Juan Erviti ,Sanofi Regeneron ,Steven Nissen ,Marc Sabatine ,Amgen ,Drug Administration ,European Medicines Agency ,Health Canada ,Phd Navarre Health Service ,Data Collection For Cardiovascular Trials Initiative ,Novartis ,Navarre Health Service ,Restoring Invisible ,Abandoned Trials ,Cleveland Clinic ,Hazard Ratio ,Still Not ,New England Journal ,European Medicines ,Open Label Extension ,Standardized Data Collection ,Cardiovascular Trials Initiative ,